Matches in SemOpenAlex for { <https://semopenalex.org/work/W2146366888> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2146366888 endingPage "404" @default.
- W2146366888 startingPage "401" @default.
- W2146366888 abstract "Buprenorphine is commonly used for opioid detoxification. The goal of this study was to determine whether a change from the intramuscular (IM) buprenorphine to the sublingual (SL) formulation of buprenorphine-naloxone was associated with improved treatment completion rates on an inpatient detoxification unit.This study was conducted at the Johns Hopkins Bayview Medical Center (JHBMC) Chemical Dependence Unit (CDU), a 26-bed, 3-day inpatient detoxification unit providing detoxification from opioids, alcohol, and sedatives. The opioid detoxification protocol was changed from IM buprenorphine (0.3 mg bid for 3 days) to SL buprenorphine-naloxone (8, 8, and 6 mg on sequential days, plus 2 mg on the morning of discharge). For the 3 months prior to and after the change in protocol, data were collected retrospectively on demographics, type of dependence being treated, and type of discharge.A total of 1,168 patients were admitted to the JHBMC CDU during the period studied. In the 3 months prior to the change in buprenorphine protocol, 353 of 483 patients admitted for treatment of opioid dependence (73.1%) completed treatment, compared with 407 of 473 patients admitted after the change (86.0%); this difference was highly significant (p < .0001). Among 212 patients who did not receive treatment for opioid dependence over the same period, the rates of treatment completion did not change significantly (89.8% before vs. 83.0% after; p = .208).A change from IM buprenorphine to SL buprenorphine-naloxone for opioid detoxification was associated with a significant improvement in completion rates at this inpatient treatment program." @default.
- W2146366888 created "2016-06-24" @default.
- W2146366888 creator A5074726856 @default.
- W2146366888 creator A5078444066 @default.
- W2146366888 date "2007-12-01" @default.
- W2146366888 modified "2023-10-16" @default.
- W2146366888 title "Treatment completion on an inpatient detoxification unit: Impact of a change to sublingual buprenorphine–naloxone" @default.
- W2146366888 cites W1966935364 @default.
- W2146366888 cites W1968666037 @default.
- W2146366888 cites W1969058086 @default.
- W2146366888 cites W1976623666 @default.
- W2146366888 cites W1977681341 @default.
- W2146366888 cites W1978130248 @default.
- W2146366888 cites W1995237720 @default.
- W2146366888 cites W2033625877 @default.
- W2146366888 cites W2039138894 @default.
- W2146366888 cites W2069043345 @default.
- W2146366888 cites W2118605713 @default.
- W2146366888 cites W2147528480 @default.
- W2146366888 cites W2253253917 @default.
- W2146366888 cites W2281201060 @default.
- W2146366888 doi "https://doi.org/10.1016/j.jsat.2007.01.004" @default.
- W2146366888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17400414" @default.
- W2146366888 hasPublicationYear "2007" @default.
- W2146366888 type Work @default.
- W2146366888 sameAs 2146366888 @default.
- W2146366888 citedByCount "9" @default.
- W2146366888 countsByYear W21463668882012 @default.
- W2146366888 countsByYear W21463668882016 @default.
- W2146366888 countsByYear W21463668882017 @default.
- W2146366888 countsByYear W21463668882018 @default.
- W2146366888 crossrefType "journal-article" @default.
- W2146366888 hasAuthorship W2146366888A5074726856 @default.
- W2146366888 hasAuthorship W2146366888A5078444066 @default.
- W2146366888 hasConcept C126322002 @default.
- W2146366888 hasConcept C142724271 @default.
- W2146366888 hasConcept C170493617 @default.
- W2146366888 hasConcept C204787440 @default.
- W2146366888 hasConcept C2778750930 @default.
- W2146366888 hasConcept C2778949969 @default.
- W2146366888 hasConcept C2779350572 @default.
- W2146366888 hasConcept C2780497538 @default.
- W2146366888 hasConcept C2781063702 @default.
- W2146366888 hasConcept C42219234 @default.
- W2146366888 hasConcept C71924100 @default.
- W2146366888 hasConceptScore W2146366888C126322002 @default.
- W2146366888 hasConceptScore W2146366888C142724271 @default.
- W2146366888 hasConceptScore W2146366888C170493617 @default.
- W2146366888 hasConceptScore W2146366888C204787440 @default.
- W2146366888 hasConceptScore W2146366888C2778750930 @default.
- W2146366888 hasConceptScore W2146366888C2778949969 @default.
- W2146366888 hasConceptScore W2146366888C2779350572 @default.
- W2146366888 hasConceptScore W2146366888C2780497538 @default.
- W2146366888 hasConceptScore W2146366888C2781063702 @default.
- W2146366888 hasConceptScore W2146366888C42219234 @default.
- W2146366888 hasConceptScore W2146366888C71924100 @default.
- W2146366888 hasIssue "4" @default.
- W2146366888 hasLocation W21463668881 @default.
- W2146366888 hasLocation W21463668882 @default.
- W2146366888 hasOpenAccess W2146366888 @default.
- W2146366888 hasPrimaryLocation W21463668881 @default.
- W2146366888 hasRelatedWork W1598952394 @default.
- W2146366888 hasRelatedWork W1982394821 @default.
- W2146366888 hasRelatedWork W1989887935 @default.
- W2146366888 hasRelatedWork W2089714039 @default.
- W2146366888 hasRelatedWork W2146366888 @default.
- W2146366888 hasRelatedWork W2332948827 @default.
- W2146366888 hasRelatedWork W2461248502 @default.
- W2146366888 hasRelatedWork W2958011020 @default.
- W2146366888 hasRelatedWork W2992412951 @default.
- W2146366888 hasRelatedWork W4237954071 @default.
- W2146366888 hasVolume "33" @default.
- W2146366888 isParatext "false" @default.
- W2146366888 isRetracted "false" @default.
- W2146366888 magId "2146366888" @default.
- W2146366888 workType "article" @default.